rts logo

Maravai LifeSciences Holdings Inc (MRVI) Stock Could Soon Reward Patient Investors

Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) is 29.92% higher on its value in year-to-date trading and has touched a low of $4.52 and a high of $16.62 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MRVI stock was last observed hovering at around $8.60 in the last trading session, with the day’s loss setting it -0.09%.

Currently trading at $8.51, the stock is 7.02% and 24.05% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.81 million and changing -1.05% at the moment leaves the stock 1.51% off its SMA200. MRVI registered -36.96% loss for a year compared to 6-month loss of -14.90%. The firm has a 50-day simple moving average (SMA 50) of $4.02 and a 200-day simple moving average (SMA200) of $1.63.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The stock witnessed a 12.12% gain in the last 1 month and extending the period to 3 months gives it a 29.92%, and is 0.24% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.53% over the week and 6.53% over the month.

Maravai LifeSciences Holdings Inc (MRVI) has around 650 employees, a market worth around $1.13B and $288.94M in sales. Fwd P/E is 185.73. Profit margin for the company is -41.19%. Distance from 52-week low is 88.27% and -48.80% from its 52-week high. The company has generated returns on investments over the last 12 months (-11.73%).

Maravai LifeSciences Holdings Inc quarterly earnings per share for the current quarter are estimated at -$0.03 with sales reaching $60.55M over the same period.The EPS is expected to shrink by -154.23% this year, but quarterly earnings will post -5.80% year-over-year. Quarterly sales are estimated to shrink -23.40% in year-over-year returns.

Maravai LifeSciences Holdings Inc (MRVI) Top Institutional Holders

307 institutions hold shares in Maravai LifeSciences Holdings Inc (MRVI), with institutional investors hold 105.10% of the company’s shares. The shares outstanding are 132.23M, and float is at 106.79M with Short Float at 6.88%. Institutions hold 102.61% of the Float.

The top institutional shareholder in the company is GTCR, LLC with over 21.68 million shares valued at $269.5 million. The investor’s holdings represent 16.43% of the MRVI Shares outstanding. As of Jun 29, 2023, the second largest holder is Massachusetts Financial Services Co. with 11.15 million shares valued at $138.65 million to account for 8.46% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 10.56 million shares representing 8.00% and valued at over $131.25 million, while Thrivent Financial For Lutherans holds 6.30% of the shares totaling 8.31 million with a market value of $103.23 million.

Related Posts